Risk-adapted management of acute pulmonary embolism: recent evidence, new guidelines.

ABSTRACT: Venous thromboembolism (VTE), the third most frequent acute cardiovascular syndrome, may cause life-threatening complications and imposes a substantial socio-economic burden. During the past years, several landmark trials paved the way towards novel strategies in acute and long-term management of patients with acute pulmonary embolism (PE). Risk stratification is increasingly recognized as a cornerstone for an adequate diagnostic and therapeutic management of the highly heterogeneous population of patients with acute PE. Recently published European Guidelines emphasize the importance of clinical prediction rules in combination with imaging procedures (assessment of right ventricular function) and laboratory biomarkers (indicative of myocardial stress or injury) for identification of normot

SUBMITTER: Kaberich A 

PROVIDER: S-EPMC4222429 | biostudies-literature | 2014 Oct

REPOSITORIES: biostudies-literature